Ann: Neuren to present at autism research meeting, page-24

I remind you that starting tomorrow we are in Seattle at the Autism Meeting:


Neuren to present at autism research meeting
Melbourne, Australia: Neuren Pharmaceuticals (ASX: NEU) today announced the acceptance of an
abstract for presentation at the 2025 International Society for Autism Research (INSAR) Annual Meeting,
being held 30 April - 3 May 2025, in Seattle Washington. Details of the presentation are as follows:
“Many Apparent False Negatives in Detection of Mutations in Gene Associated with Autism Spectrum
Disorders”
• Presentation Type: Poster
• Date: Thursday, 1 May
All INSAR Annual Meeting content to be presented or published is embargoed until the time of the
actual presentation. Posters will be embargoed until Thursday, 1 May.
Neuren Vice President of Clinical Development Nancy Jones PhD commented: “The importance of
accurate genetic testing for children with developmental delay cannot be overstated. We hope that in
bringing to light the shortcomings in current genetic testing, methodologies will improve and more
children and families can receive a diagnosis.”